Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000518720 | SCV000613844 | benign | not specified | 2017-04-14 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000727082 | SCV000705490 | uncertain significance | not provided | 2017-01-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000727082 | SCV002282970 | benign | not provided | 2023-12-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002525043 | SCV003686680 | uncertain significance | Inborn genetic diseases | 2022-07-12 | criteria provided, single submitter | clinical testing | The c.23C>G (p.S8W) alteration is located in exon 1 (coding exon 1) of the KCNC3 gene. This alteration results from a C to G substitution at nucleotide position 23, causing the serine (S) at amino acid position 8 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV000727082 | SCV004033698 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | KCNC3: PP2, PP3, BS1 |
Prevention |
RCV003942692 | SCV004772163 | likely benign | KCNC3-related disorder | 2020-03-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |